1,4-androstadiene-3,17-dione has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alves, JMP; Devendran, S; Erdman, JW; Hudson, ME; Ly, LK; Morris, DJ; Paul, HM; Ridlon, JM; Rowles, JL; Wolf, PM; Yemm, C | 1 |
1 other study(ies) available for 1,4-androstadiene-3,17-dione and Prostatic Neoplasms
Article | Year |
---|---|
Bacterial steroid-17,20-desmolase is a taxonomically rare enzymatic pathway that converts prednisone to 1,4-androstanediene-3,11,17-trione, a metabolite that causes proliferation of prostate cancer cells.
Topics: Adrenal Glands; Androgens; Androstadienes; Cell Line, Tumor; Cell Proliferation; Clostridiales; Glucocorticoids; Humans; Hydrocortisone; Male; Metabolic Networks and Pathways; Phylogeny; Prednisolone; Prednisone; Propionibacteriaceae; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase | 2020 |